Novel biomarkers in vascular remodelling and inflammation in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a progressive and fatal disease driven by vascular remodelling and inflammation. Presenting symptoms of PAH are nonspecific, making diagnosis often late when the disease is irreversible. Endothelial damage occurs early in the disease progress and medial thick...
Main Author: | Gurung, R. |
---|---|
Other Authors: | Clapp, L. ; Klein, N. |
Published: |
University College London (University of London)
2016
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746237 |
Similar Items
-
Vascular reactivity in pulmonary resistance arteries : influence of pulmonary hypertension and endothelin
by: McCulloch, Kirsty Mary
Published: (1996) -
FDG-PET imaging of pulmonary vascular remodelling in PAH
by: Wang, Lei
Published: (2016) -
Inflammation in pulmonary arterial hypertension : NF-kappa B signalling and the role of corticosteroids
by: Price, Laura
Published: (2013) -
Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
by: Jane A. Leopold, et al.
Published: (2016-05-01) -
Arterial stiffness, macro-vascular, micro-vascular endothelial function and cardiac remodelling in arterial fibrillation
by: Krishnamoorthy, Suresh
Published: (2015)